Directorate-General for Research & Innovation logo Horizon: the EU Research & Innovation magazine | European Commission logo
Receive our editor’s picks

Views

interview | coronavirus outbreak | health
26 June 2020

Q&A: ‘We are only at the beginning of the coronavirus pandemic’ – Prof. Peter Piot

We’re only at the start of the coronavirus pandemic although the second wave may take a different form to the first one, says veteran virologist Professor Peter Piot, who has spent the past 40 years tracking down and fighting viruses.

The immune system is changing all the time and Dr Aleksandra Walczak wants to distinguish between genuine responses and random fluctuations. Image credit - B. Eymann - Académie des sciences
interview | coronavirus outbreak | health | frontier research
16 June 2020

Q&A: How physics could explain why people respond differently to coronavirus infection

Some people’s immune systems contain pre-existing protection against coronavirus, indicating that they have encountered a similar infection to Covid-19 before, according to Dr Aleksandra Walczak, a physicist at École Normale Supérieure in Paris, France.

Prof. Baldwin says there are still many gaps in our knowledge of how to treat anxiety disorders, especially when therapy and anti-depressants do not work. Image credit - David Baldwin
interview | health
09 June 2020

Q&A: When and how does anxiety become a problem?

Short-term anxiety is a normal response to stress, but more needs to be done to understand and treat longer-term anxiety disorders, which affect the lives of millions of people across Europe and impose a significant economic burden on society, according to Professor David Baldwin, head of the mental health group at the University of Southampton, UK.

Covid-19 has shown us that countries that we thought were well prepared for something like coronavirus, were not, says Prof. McInnes. Image credit - Aberystwyth University
interview | coronavirus outbreak | health | frontier research
04 June 2020

Q&A: Coronavirus has shown the need for a global health system – but revealed its weaknesses too

We are seeing a failure of global health governance in response to Covid-19 because there are too many agencies with different interests, according Professor Colin McInnes, pro-vice chancellor at Aberystwyth University in Wales, UK, who says global institutions such as the World Health Organization and World Bank should stand together in crises.

We will see increasing inequality and serious health implications if we do not change our food systems, says Prof. Peter Jackson. Image credit - Peter Jackson
interview | coronavirus outbreak
04 May 2020

Q&A: Covid-19 pandemic highlights urgent need to change Europe’s food system

Europe urgently needs to make its food system more sustainable – or else face growing food insecurity and health impacts – and the coronavirus pandemic offers us an opportunity to push for change, according to Professor Peter Jackson.

Professor Cecilia Mascolo at the University of Cambridge, UK, hopes her coronavirus sounds app could provide the data needed to build a quick and cheap Covid-19 screening test in the future. Image credit - Salvatore Scellato
interview | health | coronavirus outbreak | ict | frontier research
30 April 2020

Q&A: The sound of your voice could help fight Covid-19

A recording of a cough, the noise of a person’s breathing or even the sound of their voice could be used to help diagnose patients with Covid-19 in the future, according to Professor Cecilia Mascolo, an expert in mobile health at data analysis at the University of Cambridge, UK.

Coronavirus lockdowns have caused air pollution to drop. Science is probing whether air pollution worsens the effects of coronavirus, with recent studies including in Italy suggesting there’s a link between polluted areas and higher fatality risk. Image credit - European Space Agency/ licenced under CC BY-SA 3.0 IGO
interview | health | coronavirus outbreak
22 April 2020

Q&A: China and Europe likely to see different effect of coronavirus-related air pollution drop

In March, a study revealed that between 50,000 and 100,000 deaths could be avoided this year in China if air pollution stayed at the same level as during the coronavirus lockdown. While other parts of the world have also seen improvements in air quality, the impact in Europe is likely to be less dramatic than for China, according to Dr Kristin Aunan from the Centre for International Climate Research (CICERO) in Norway, who conducted the study.

Jan Wörner says that discovery is in humans' DNA. Image credit - ESA/Sabine Grothues, licenced under CC BY-SA 3.0
interview | space
10 April 2020

Q&A: Human spaceflight is a risk worth taking, says ESA head

Human spaceflight is dangerous, but worth the risk, according to Jan Wörner, the Director General of the European Space Agency (ESA). But even so, there are limits – like Mars. Robots, as proxies for human exploration, can take on dangerous missions by travelling to places astronauts are not yet capable of reaching, but they can never replace what we learn from putting women and men in space, according Wörner.

Habitat loss such as forest clearing or mining operations can increase the chance of a disease jumping from animals to humans, says Prof. Koopmans. Image credit - M.P.G. Koopmans, Erasmus MC 2020
coronavirus outbreak | interview | health
02 April 2020

Q&A: We have to rethink disease detection to get ahead of the outbreak after coronavirus

We know that outbreaks like coronavirus will become more common in the future and tackling them is the Apollo programme of our time, according to Professor Marion Koopmans, head of the viroscience department at Erasmus University Medical Centre in Rotterdam, the Netherlands. 

According to Prof. Bekeredjian-Ding, an approved mRNA coronavirus vaccine would be easier and faster to produce and thus deploy worldwide than a conventional vaccine. Image credit - Unsplash/Liliya Lisa
coronavirus outbreak | interview | health
01 April 2020

Five things you need to know about: mRNA vaccines

The race for a vaccine against the novel coronavirus, or SARS-CoV-2, is on, with 54 different vaccines under development, two of which are already being tested in humans, according to the World Health Organization. And among the different candidates is a new player on the scene – mRNA vaccines.

Pages